Interested in some of the commentary about expected share price...

Interested in some of the commentary about expected share price after first readout, particularly those correlating an increased share price with increased magnitude of effect measured by letters gained as a marker of visual acuity.

The study will be powered to show a statistically significant change in letters gained. Above this result the drug is likely to gain approval as a treatment, below it will not. My reading of comments made by the company over the past few years is that this number is somewhere between 2.5 and 3 letters.

I personally see this as a pretty binary outcome - below 2.5-3 letters it will be a wipeout (20-25c if I had to guess), above 3 letters it will fly (> $2 bearing in mind there will be a cap raise before Q3) with more to come if second trial positive obviously. I personally don't think a bigger increase in letters gained will have that much of an effect on share price but this is my opinion only.

I've sold a significant % of my holding at tidy profit in last month as IMO the easy money has already been made but still hold some for the result. GLAH.